MedTrace Logo

Long-term Follow-up of the Helsinki Businessmen Study

NCT02526082 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3490

Last updated 2015-08-18

No results posted yet for this study

Summary

The Helsinki Businessmen Study (HBS) is a clinico-epidemiological longitudinal study started in 1964. It also included a 5-year randomized, controlled multifactorial primary prevention trial of cardiovascular diseases between 1974-1980. The cohort is being actively followed-up through national registers since the 1980, and since 2000 with regular questionnaire surveys. Latest in 2015. Also clinical and laboratory studies have been performed in random subcohorts. Follow-up is ongoing with new hypothesis-generating research questions.

Conditions

Interventions

OTHER

Intervention

Multifactorial intervention with lifestyle changes and drugs as needed

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Timo E Strandberg, MD · Helsinki University Central Hospital

Eligibility

Min Age
31 Years
Max Age
46 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1964-01-31
Primary Completion
2040-12-31
Completion
2040-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526082 on ClinicalTrials.gov